VALENCIA, Calif. – Oct. 7, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today...
Nusano Presenting at Industry Events in October
read more
News
Nusano Adds to Executive Leadership Team in Advance of 2025 Commercialization
VALENCIA, Calif. – Oct. 3, 2024 – Nusano, Inc., a physics company transforming the production of medical...
Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes
Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial...
Nusano Named to Insights Care 5 Most Trusted Radiopharmaceutical Companies to Watch
September 2024 – Insights Care recently interviewed Nusano CEO Chris Lowe for its "5 Most Trusted Radiopharmaceutical...
Nusano Featured in Biosphere Magazine
Nusano is featured in the 2024 edition of Biosphere magazine entitled "Profiles in Innovation." Published by BioUtah,...
Nusano and PharmaLogic Announce Strategic Supply Agreement to Enable Current and Emerging Radiopharmaceuticals
Nusano and PharmaLogic announced a supply agreement to provide a more efficient and reliable supply of critical radioisotopes. The agreement will increase access to on-demand radioisotope supplies provided by Nusano for use in pharmaceutical products produced in PharmaLogic’s network of facilities.
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates